Lin Ge

Member of the Communist Party of China, researcher, doctoral supervisor, recipient of special government allowance from Hunan Province, currently serves as the Party Secretary and President of CITIC Xiangya Reproductive and Genetic Specialty Hospital, director of the State Key Laboratory of Human Stem Cells and Reproductive Engineering of the National Health Commission, executive member of the Reproductive Medicine Professional Committee of the Chinese Medical Doctor Association, member of the National Stem Cell Clinical Research Expert Committee, executive member of the Fertility Preservation Professional Committee of the China Women and Children Health Care Association, member of the Hunan Provincial Stem Cell Clinical Research Expert Committee, vice chairman of the Hunan Provincial Reproductive Medicine Professional Committee, executive member of the 10th Provincial Committee of the Hunan Provincial Association for Science and Technology, executive director of the Hunan Provincial Women and Children Health Care and Eugenics Association, editorial board member of Stem Cells, and many other positions.

His main research areas include human embryonic stem cells and related research on human assisted reproductive laboratory technology. His research team established China's first human embryonic stem cell line in 2001, which has now developed into an embryonic stem cell bank with independent intellectual property rights; he was the first to establish the first hESCs line and hESCs bank in China, established key technical platforms such as the differentiation of hESCs into functional cells, and invented a new method of somatic cell nuclear transfer, obtaining the world's first human therapeutic cloned embryo and the first therapeutic cloned blastocyst; established the world's first batch of platforms using next-generation sequencing technology to conduct PGD/PGS detection and gave birth to China's first "cancer-free baby"; developed the "MicroSeq" new technology, etc.

He has successively presided over and participated in 14 projects, including Hunan Provincial Science and Technology Department industry-university-research platform projects, 863 projects, 973 projects, National Natural Science Foundation of China Excellent Young Scientists Fund, Ministry of Health public welfare industry research projects, the Ministry of Education New Century Excellent Talents Support Program, the national "13th Five-Year Plan" key research and development plan, and major projects of Hunan Province.

As the main completer, he successively won the "National Science and Technology Progress Award Second Prize" (ranked 5th) in 2009, the "Hunan Provincial Science and Technology Progress Award First Prize" (ranked 1st) in 2013, and the "Hunan Provincial Science and Technology Innovation Team Award" in 2017.

He has published more than 130 papers in renowned SCI journals such as Cell Stem Cell, Nature Communications, Cell Research, EBiomedicine, and Human Reproduction, co-authored one monograph "Assisted Reproductive Laboratory Technology", participated in the formulation of one national pharmaceutical industry standard, one industry guideline, and four expert consensuses, and obtained 57 authorized patents, including 6 invention patents. He has successively won many honors, including the Ministry of Education "New Century Excellent Talents", Changsha City "Science and Technology Innovation and Entrepreneurship Leading Talents", the National Hundred, Thousand and Ten Thousand Talents Project "Young and Middle-aged Experts with Outstanding Contributions", "Experts Enjoying Special Government Allowances from the State Council", "Hunan Provincial May 1st Labor Medal", and Hunan Enterprise "Innovation Elite".